Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Baxter
Moodys
Dow
US Army
AstraZeneca
Cipla
Federal Trade Commission

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020899

« Back to Dashboard

NDA 020899 describes OPTISON, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the OPTISON profile page.

The generic ingredient in OPTISON is albumin human. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the albumin human profile page.
Summary for 020899
Tradename:OPTISON
Applicant:Ge Healthcare
Ingredient:albumin human
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 020899
Mechanism of ActionUltrasound Contrast Activity
Suppliers and Packaging for NDA: 020899
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OPTISON albumin human INJECTABLE;INJECTION 020899 NDA GE Healthcare Inc. 0407-2707 N 0407-2707-03
OPTISON albumin human INJECTABLE;INJECTION 020899 NDA GE Healthcare Inc. 0407-2707 N 0407-2707-18

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Dec 31, 1997TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Apr 20, 2021Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 020899

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare OPTISON albumin human INJECTABLE;INJECTION 020899-001 Dec 31, 1997 ➤ Sign Up ➤ Sign Up
Ge Healthcare OPTISON albumin human INJECTABLE;INJECTION 020899-001 Dec 31, 1997 ➤ Sign Up ➤ Sign Up
Ge Healthcare OPTISON albumin human INJECTABLE;INJECTION 020899-001 Dec 31, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Deloitte
US Department of Justice
Accenture
McKinsey
McKesson
Queensland Health
Chinese Patent Office
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.